Timing note: Allegion is scheduled to report today, Thursday, July 23, 2026, before the market opens—not tomorrow. The earnings call begins at 8:00 a.m. ET. (investor.allegion.com)
Allegion enters Q2 with a healthy core Americas franchise but several execution questions left over from Q1. The most important issue is not whether reported revenue grows—acquisitions, pricing and currency should make that relatively straightforward—but whether the company can stabilize margins, restore International operations and preserve confidence in its back-half earnings ramp.
Consensus calls for approximately $2.21 of adjusted EPS on $1.11 billion of revenue, representing year-over-year growth of roughly 8% and 9%, respectively. (benzinga.com)
| Metric | Q2 2026 consensus | Q2 2025 actual | Implied growth |
|---|---|---|---|
| Revenue | ~$1.11B | $1.022B | ~9% |
| Adjusted EPS | ~$2.21 | $2.04 | ~8% |
| Adjusted operating margin | No reliable consensus disclosed | 23.7% | Margin bridge is key |
Allegion's current full-year outlook calls for:
The company affirmed the organic-growth and adjusted-EPS ranges after Q1 while increasing reported revenue guidance to incorporate the DCI acquisition. (investor.allegion.com)
Allegion Americas remains the center of the investment case. In Q1:
The quality of Q2 growth matters. Q1 enterprise organic growth was generated by pricing while total volume declined. Investors should therefore distinguish between:
A favorable report would show continued healthy commercial and institutional demand, positive nonresidential volume and electronics once again outgrowing the mechanical portfolio.
Key questions for management:
Q1 adjusted operating margin fell 150 basis points to 21.2%, despite nearly 10% reported revenue growth. Americas adjusted margin declined 110 basis points to 28.1%, reflecting lower residential volume, unfavorable product mix, foreign-exchange effects and acquisition dilution.
Management previously indicated that:
That makes the Q2 margin bridge critical. Investors will want evidence that price and productivity are covering inflation in dollars, even if pricing mechanically dilutes the margin percentage.
The best outcome would be:
Conversely, strong reported revenue paired with another large margin decline would reinforce concerns that acquisitions and pricing are masking weaker underlying operating leverage.
International was the clear Q1 disappointment:
The company characterized this as an execution problem rather than a demand problem, pointing to retained orders and backlog. It expected production rates to improve and the Q1 shortfall to be recovered over the remainder of 2026.
Q2 does not necessarily need to show a complete recovery. It does, however, need to demonstrate clear sequential progress. Investors should look for:
A delayed recovery would put more pressure on Q3 and Q4 and could undermine the full-year EPS outlook.
If Allegion reports the consensus $2.21 in Q2, first-half adjusted EPS would be approximately $4.01. The midpoint of the $8.70–$8.90 full-year range would then require about $4.79 in second-half EPS.
That would represent roughly 13% growth over the $4.24 Allegion earned in the second half of 2025.
The required acceleration is plausible, given easier margin comparisons, expected ERP recovery and positive nonresidential volume. But it leaves less room for:
As a result, a simple guidance reiteration may not be enough to drive a favorable reaction. Investors will want management to explain why the back-half margin and earnings ramp remains achievable.
After Q1, Allegion estimated an incremental inflationary headwind equal to approximately 1% of cost of goods sold, reflecting tariffs and other input costs. The company expected to offset that pressure through pricing and cost actions, leaving adjusted operating-income dollars and EPS neutral.
The primary risk is timing: inflation may reach the income statement before all pricing actions take effect. Questions include:
Neutralization in profit dollars would be acceptable. Margin-rate expansion is a higher hurdle because price-driven revenue increases can dilute the percentage margin even when they preserve earnings.
DCI expands Allegion's hollow-metal doors and frames presence on the West Coast, reducing freight costs and shortening lead times. Management described DCI as a low-double-digit EBITDA-margin business with limited 2026 EPS accretion.
The near-term financial impact is therefore mixed:
Investors should focus on whether DCI is growing faster under Allegion, whether margins are improving and whether it is helping the broader nonresidential portfolio win projects.
ALLE closed around $140 on July 22. The shares are down approximately 12% from year-end 2025, while the S&P 500 proxy SPY is up roughly 10%.
At that price, ALLE trades at about 15.9 times the midpoint of management's 2026 adjusted-EPS guidance. That is not a demanding multiple if Allegion can deliver the guide, restore margin momentum and maintain mid-single-digit nonresidential growth.
However, the discount partly reflects two consecutive consensus EPS misses and concern that 2026 earnings have become increasingly back-half weighted. (benzinga.com)
This would support the view that Q1 was a temporary execution setback and could drive valuation re-expansion.
The reaction would likely depend on the credibility and specificity of management's Q3/Q4 commentary.
That outcome would raise questions about execution, acquisition quality and the sustainability of Allegion's premium margin structure.
This is primarily an execution and margin quarter, not a top-line quarter.
The Americas nonresidential franchise appears fundamentally healthy, and acquisitions and pricing should support strong reported revenue. The debate is whether Allegion can convert that growth into earnings while repairing International operations and managing tariff inflation.
The three most important indicators are:
A consensus-level quarter accompanied by credible International recovery and stable guidance would likely be acceptable given the stock's underperformance. A clean beat with improving organic volume and margins could materially improve sentiment. Another margin or execution miss would make the $8.70–$8.90 full-year EPS range increasingly difficult to defend.